Transparens - NHS approves first non-hormonal hot flush drug

Transparens

NHS approves first non-hormonal hot flush drug

Tillförlitlighet

Styrkt

Baserat på 9 källor

Källmångfald

Stora medier (9)

Källor (9)

13 påståenden

5 frågor

What are the specific results of the ongoing clinical trials of fezolinetant in breast cancer patients?

When will fezolinetant be available on the NHS for breast cancer patients?

What is the exact cost of fezolinetant and how does it compare to HRT?

What are the long-term side effects of fezolinetant?

How many women in the UK are currently prescribed fezolinetant?

sensitive_data

Allvarlig sjukdom

y increase the risk of breast cancer. Women who do not take HRT du

sensitive_data

Allvarlig sjukdom

bed the drug. However, breast cancer patients who go through medic

sensitive_data

Allvarlig sjukdom

London, described how breast cancer treatments can cause a rapid

sensitive_data

Allvarlig sjukdom

still being tested on breast cancer patients, and they must wait

Denna artikel producerades av Reed News med hjälp av AI. Alla påståenden korsrefereras mot flera källor.